Well said on the XBI. The great results from JNJ and BIIB will lure funds back in as bios are one of the few sectors still has considerable growth left. Innovation, M&A, aging population..you name it. Also this sector is immune to oil and what happens in China.
Having said that, pricing concerns/pressure is overblown too.
On RLYP, agree and it is one step closer to buyout now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.